Breast cancer patients can reduce their risk of recurrence

Article

A few blogs ago I told you about my discussion with Otis Brawley, MD, the chief medical officer of ACS and his message that we have to use what we know to prevent cancer and be well, and it comes down to applying what we know about healthy living , meaning diet, nutrition, stress management, exercise, and the kind of psychological support we get from loving and supportive relationships. I just heard the same message from Dean Ornish, MD, who has been promoting healthy lifestyle as a way to cure heart disease for more than two decades. Ornish was speaking at the annual meeting of the Society for Integrative Oncology in New York City. This meeting brought researchers from 19 countries with 25 different degrees to New York City to discuss the power of complementary healing modalities for cancer. Ornish's research is just as compelling now and he has offered a number of studies about the power of lifestyle change and its impact on cancer. Repeatedly, the researchers here have offered studies, well designed scientific research, on the power of the patient in being a part of his or her own cure. This is a hard thing to write about without it sounding like there is some kind of blame being placed for getting cancer or for not being able to impact your own ability to impact cure, but in no way should you read it that way. Instead look at the research the same way you would if you were considering a drug to help you get better. For example, I was excited to hear David Servan-Schreiber, MD, PhD, talk about the research of Barbara Anderson, PhD, at the University of Ohio, which you will read in the cover story of the Winter Issue of CURE. Anderson has followed a large contingent of breast cancer patients for more than six years. Half of them were followed with no intervention and the other half were enrolled in stress reduction program that had a number of components to it, such as relaxation, meditation, problem solving, finding community support, and exercise. What she found was a 68 percent reduction in recurrence in the group doing the stress reduction. Servan-Schreiber, the survivor of a recurrent brain tumor and author of Anticancer, brought up Anderson's research, saying that if there was a drug that offered this kind of response and it was not given to patients, the doctor would be sued. I agree. So why are women not being told about these findings much less being offered the same support. I asked Barbara Anderson this question while talking to her about the research. She said she didn't have any idea. So spread the word, ask your oncologist about Anderson's research. It was reported in 2008 in the journal Cancer. Get the article; send it to every one you know.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content